ganitumab
ganitumab noun: a human monoclonal antibody against type 1 insulin-like growth factor receptor, designed for the treatment of cancers.
Noun
ganitumab (uncountable)
- A human monoclonal antibody against type 1 insulin-like growth factor receptor, designed for the treatment of cancers.
- While a randomized Phase II study testing the addition of the IGF1R mab ganitumab to chemotherapy in EWS is ongoing (NCT02306161), CAR T cells targeting IGF1R may be an alternative treatment for high risk patients with EWS and other sarcomas.2015 July 15, “IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas”, in PLOS ONE, →DOI
Origin of ganitumab
From -tu- (“tumor”) + -umab (“human monoclonal antibody”).
Questions about ganitumab
- What does ganitumab mean?
- Ganitumab means a human monoclonal antibody against type 1 insulin-like growth factor receptor, designed for the treatment of cancers.
- What part of speech is ganitumab?
- Ganitumab is a noun.
Words near ganitumab in the dictionary
Source and license
Adapted from Wiktionary: ganitumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “ganitumab.” Word.ws, https://word.ws/ganitumab. Based on Wiktionary, CC BY-SA 4.0.
